| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |